Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study

PURPOSE: This study was performed to investigate the efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer (NSCLC) in the real world. METHODS: Data on clinicopathological features, efficacy and adverse events (AEs) were collected retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ke, Guo, Qianqian, Li, Xingya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197234/
https://www.ncbi.nlm.nih.gov/pubmed/37208639
http://dx.doi.org/10.1186/s12890-023-02470-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197234/
https://www.ncbi.nlm.nih.gov/pubmed/37208639
http://dx.doi.org/10.1186/s12890-023-02470-z

Ejemplares similares